Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan-R Targan

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Gastroenterology|June 9, 2005
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's diseaseStephan R Targan, Carol J Landers, Huiying Yang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytesHon Wai Koon, David Q Shih, Tressia C Hing, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
A blood-based transcriptomic signature stratifies severe Crohn's disease and defines potentially targetable therapeutic pathwaysRivkah Gonsky, Evan Adams, Alka A Potdar, et al.
Mediators of Inflammation|July 14, 2021
Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal FibrosisJia Wenxiu, Yang Mingyue, Han Fei, et al.
Digestive Diseases and Sciences|December 20, 2012
Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scaleBijal Surti, Brennan Spiegel, Andrew Ippoliti, et al.
Inflammatory Bowel Diseases|November 23, 2006
Antibodies to I2 predict clinical response to fecal diversion in Crohn's diseaseJacob Spivak, Carol J Landers, Eric A Vasiliauskas, et al.
Journal of Leukocyte Biology|October 14, 2016
The TNF family member TL1A induces IL-22 secretion in committed human T<sub>h</sub>17 cells via IL-9 inductionLisa S Thomas, Stephan R Targan, Masato Tsuda, et al.
Inflammatory Bowel Diseases|June 4, 2018
Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like CharacteristicsDalin Li, Talin Haritunians, Carol Landers, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 22, 2021
Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosisAdam Truong, Karen N Zaghiyan, James Mirocha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2007
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control studyGil Y Melmed, Robert Elashoff, Gary C Chen, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Gastroenterology|June 9, 2005
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's diseaseStephan R Targan, Carol J Landers, Huiying Yang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytesHon Wai Koon, David Q Shih, Tressia C Hing, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
A blood-based transcriptomic signature stratifies severe Crohn's disease and defines potentially targetable therapeutic pathwaysRivkah Gonsky, Evan Adams, Alka A Potdar, et al.
Mediators of Inflammation|July 14, 2021
Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal FibrosisJia Wenxiu, Yang Mingyue, Han Fei, et al.
Digestive Diseases and Sciences|December 20, 2012
Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scaleBijal Surti, Brennan Spiegel, Andrew Ippoliti, et al.
Inflammatory Bowel Diseases|November 23, 2006
Antibodies to I2 predict clinical response to fecal diversion in Crohn's diseaseJacob Spivak, Carol J Landers, Eric A Vasiliauskas, et al.
Journal of Leukocyte Biology|October 14, 2016
The TNF family member TL1A induces IL-22 secretion in committed human T<sub>h</sub>17 cells via IL-9 inductionLisa S Thomas, Stephan R Targan, Masato Tsuda, et al.
Inflammatory Bowel Diseases|June 4, 2018
Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like CharacteristicsDalin Li, Talin Haritunians, Carol Landers, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 22, 2021
Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosisAdam Truong, Karen N Zaghiyan, James Mirocha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2007
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control studyGil Y Melmed, Robert Elashoff, Gary C Chen, et al.
Pageof 19